BONNIE WARNER: Open Payments
NPI 1013200534 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,396 in 75 payments from 16 companies in 2025. Trend: 2023 $1,618 · 2024 $1,736 · 2025 $1,396
Food & beverage: $1,396
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $285 |
| PFIZER INC. | 16 | $211 |
| Amgen Inc. | 13 | $151 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $146 |
| Phathom Pharmaceuticals, Inc. | 3 | $105 |
| Novartis Pharmaceuticals Corporation | 4 | $97 |
| Esperion Therapeutics, Inc. | 6 | $96 |
| Novo Nordisk Inc | 4 | $71 |
| Exact Sciences Corporation | 3 | $49 |
| Axsome Therapeutics, Inc. | 2 | $42 |
Products named: FARXIGA, JARDIANCE, OTEZLA, VOQUEZNA, PREVNAR 20, LEQVIO, NEXLETOL, NURTEC ODT.
Industry payments across KY — which companies pay providers there.
